19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Previous pirfenidone trials have only involved patients with mild-to-moderate idiopathic pulmonary fibrosis (IPF). The aim of this study was to investigate the safety and efficacy of pirfenidone in patients with mild-to-severe IPF in clinical practice.

          Related collections

          Author and article information

          Journal
          Respir Med
          Respiratory medicine
          1532-3064
          0954-6111
          Sep 2013
          : 107
          : 9
          Affiliations
          [1 ] Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-higashi, Kanazawa-ku, 236-0051 Yokohama, Japan. b980013@yahoo.co.jp
          Article
          S0954-6111(13)00223-0
          10.1016/j.rmed.2013.06.011
          23849626
          71fbc286-9117-4462-8ecd-346016c0f4c4
          Copyright © 2013 Elsevier Ltd. All rights reserved.
          History

          Diffusion capacity of the lung for carbon monoxide,Forced vital capacity,Idiopathic pulmonary fibrosis,Interstitial pneumonia,Lung function test,Pirfenidone

          Comments

          Comment on this article